Gregory J. Flesher, Chief Executive Officer at Novus Therapeutics, Inc. (NVUS), sold 14,638 shares at $1.96 ($29K) on 2019-05-20, disclosed to the SEC on 2019-05-22.
Open-market sale of $29k NVUS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.96 | 11,701 | $23K | 80.3% |
| 2 | $1.91 | 2,937 | $6K | 19.7% |
| Total | $1.95 avg | 14,638 | $29K | 100% |
| Filing → |